Simulations Plus, Inc. (SLP)
USD 24.41
(-4.96%)
USD 24.41
(-4.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 6.13 Million USD | -29.73% |
| 2023 | 8.72 Million USD | -23.04% |
| 2022 | 11.33 Million USD | 44.16% |
| 2021 | 7.86 Million USD | -11.55% |
| 2020 | 8.89 Million USD | -16.51% |
| 2019 | 10.64 Million USD | 3.41% |
| 2018 | 10.29 Million USD | 24.61% |
| 2017 | 8.26 Million USD | 14.28% |
| 2016 | 7.23 Million USD | 23.48% |
| 2015 | 5.85 Million USD | 31.92% |
| 2014 | 4.43 Million USD | 9.01% |
| 2013 | 4.07 Million USD | 12.75% |
| 2012 | 3.61 Million USD | 0.32% |
| 2011 | 3.6 Million USD | 25.43% |
| 2010 | 2.87 Million USD | 58.44% |
| 2009 | 1.81 Million USD | -16.82% |
| 2008 | 2.17 Million USD | -12.97% |
| 2007 | 2.5 Million USD | 200.41% |
| 2006 | 833.13 Thousand USD | 181.06% |
| 2005 | 296.42 Thousand USD | -52.66% |
| 2004 | 626.23 Thousand USD | -50.51% |
| 2003 | 1.26 Million USD | 153.03% |
| 2002 | 500.11 Thousand USD | 347.64% |
| 2001 | -201.94 Thousand USD | 14.67% |
| 2000 | -236.66 Thousand USD | 66.62% |
| 1999 | -709.04 Thousand USD | 67.54% |
| 1998 | -2.18 Million USD | -86.82% |
| 1997 | -1.16 Million USD | -684.64% |
| 1996 | 200 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 960 Thousand USD | 438.03% |
| 2024 Q3 | 1.88 Million USD | -57.68% |
| 2024 Q4 | 6.8 Million USD | -161.22% |
| 2024 Q2 | 4.44 Million USD | 362.71% |
| 2023 Q4 | -284 Thousand USD | -104.76% |
| 2023 Q1 | -45 Thousand USD | -106.48% |
| 2023 FY | 8.72 Million USD | -23.04% |
| 2023 Q2 | 3.09 Million USD | 6986.67% |
| 2023 Q3 | 5.96 Million USD | 92.35% |
| 2022 Q1 | 3.79 Million USD | 2091.33% |
| 2022 FY | 11.33 Million USD | 44.16% |
| 2022 Q4 | 694 Thousand USD | -85.97% |
| 2022 Q3 | 4.94 Million USD | -11.8% |
| 2022 Q2 | 5.6 Million USD | 47.93% |
| 2021 Q4 | 173 Thousand USD | -96.19% |
| 2021 Q1 | 3.05 Million USD | 38.43% |
| 2021 Q3 | 4.54 Million USD | 30.29% |
| 2021 Q2 | 3.48 Million USD | 14.26% |
| 2021 FY | 7.86 Million USD | -11.55% |
| 2020 Q4 | 2.2 Million USD | -42.85% |
| 2020 FY | 8.89 Million USD | -16.51% |
| 2020 Q1 | 2.71 Million USD | 39.42% |
| 2020 Q2 | 2.82 Million USD | 3.95% |
| 2020 Q3 | 3.85 Million USD | 36.48% |
| 2019 Q1 | 2.08 Million USD | 9.88% |
| 2019 Q2 | 2.73 Million USD | 30.83% |
| 2019 Q3 | 3.88 Million USD | 42.19% |
| 2019 Q4 | 1.94 Million USD | -49.77% |
| 2019 FY | 10.64 Million USD | 3.41% |
| 2018 Q4 | 1.89 Million USD | -44.43% |
| 2018 Q2 | 2.41 Million USD | -5.72% |
| 2018 FY | 10.29 Million USD | 24.61% |
| 2018 Q1 | 2.56 Million USD | 77.29% |
| 2018 Q3 | 3.41 Million USD | 41.39% |
| 2017 Q3 | 3.09 Million USD | 72.43% |
| 2017 Q2 | 1.79 Million USD | -6.9% |
| 2017 Q1 | 1.92 Million USD | 92.76% |
| 2017 FY | 8.26 Million USD | 14.28% |
| 2017 Q4 | 1.44 Million USD | -53.28% |
| 2016 FY | 7.23 Million USD | 23.48% |
| 2016 Q1 | 1.72 Million USD | 121.97% |
| 2016 Q2 | 1.71 Million USD | -0.68% |
| 2016 Q4 | 1 Million USD | -64.13% |
| 2016 Q3 | 2.78 Million USD | 62.51% |
| 2015 Q2 | 1.47 Million USD | 96.84% |
| 2015 Q1 | 749.37 Thousand USD | 173.21% |
| 2015 FY | 5.85 Million USD | 31.92% |
| 2015 Q3 | 2.85 Million USD | 93.47% |
| 2015 Q4 | 778.28 Thousand USD | -72.73% |
| 2014 Q3 | 2.07 Million USD | 83.26% |
| 2014 FY | 4.43 Million USD | 9.01% |
| 2014 Q1 | 959.37 Thousand USD | 315.54% |
| 2014 Q2 | 1.13 Million USD | 17.97% |
| 2014 Q4 | 274.29 Thousand USD | -86.77% |
| 2013 Q3 | 1.53 Million USD | 1.05% |
| 2013 FY | 4.07 Million USD | 12.75% |
| 2013 Q1 | 791.82 Thousand USD | 180.67% |
| 2013 Q2 | 1.51 Million USD | 91.56% |
| 2013 Q4 | 230.87 Thousand USD | -84.94% |
| 2012 Q3 | 1.21 Million USD | 3.65% |
| 2012 FY | 3.61 Million USD | 0.32% |
| 2012 Q1 | 943.53 Thousand USD | 726.78% |
| 2012 Q2 | 1.17 Million USD | 24.19% |
| 2012 Q4 | 282.12 Thousand USD | -76.77% |
| 2011 Q1 | 799.88 Thousand USD | 142.33% |
| 2011 Q3 | 1.32 Million USD | -3.27% |
| 2011 Q2 | 1.36 Million USD | 70.72% |
| 2011 Q4 | 114.12 Thousand USD | -91.36% |
| 2011 FY | 3.6 Million USD | 25.43% |
| 2010 FY | 2.87 Million USD | 58.44% |
| 2010 Q4 | 330.07 Thousand USD | -69.08% |
| 2010 Q3 | 1.06 Million USD | 17.54% |
| 2010 Q2 | 908.32 Thousand USD | 60.89% |
| 2010 Q1 | 564.56 Thousand USD | 905.3% |
| 2009 Q1 | 401.74 Thousand USD | 2353.58% |
| 2009 Q4 | 56.15 Thousand USD | -93.37% |
| 2009 Q3 | 847.12 Thousand USD | 67.15% |
| 2009 FY | 1.81 Million USD | -16.82% |
| 2009 Q2 | 506.79 Thousand USD | 26.15% |
| 2008 FY | 2.17 Million USD | -12.97% |
| 2008 Q4 | 16.37 Thousand USD | -98.61% |
| 2008 Q3 | 1.18 Million USD | 84.5% |
| 2008 Q2 | 639.77 Thousand USD | -44.67% |
| 2008 Q1 | 1.15 Million USD | 81.89% |
| 2007 Q2 | 824.18 Thousand USD | 1004.71% |
| 2007 Q3 | 968.33 Thousand USD | 17.49% |
| 2007 Q4 | 635.67 Thousand USD | -34.35% |
| 2007 FY | 2.5 Million USD | 200.41% |
| 2007 Q1 | 74.6 Thousand USD | -78.32% |
| 2006 Q1 | -238.76 Thousand USD | -378.45% |
| 2006 FY | 833.13 Thousand USD | 181.06% |
| 2006 Q3 | 440.53 Thousand USD | 53.35% |
| 2006 Q2 | 287.27 Thousand USD | 220.32% |
| 2006 Q4 | 344.08 Thousand USD | -21.89% |
| 2005 Q4 | 85.74 Thousand USD | -60.61% |
| 2005 FY | 296.42 Thousand USD | -52.66% |
| 2005 Q2 | -5689.00 USD | -340.67% |
| 2005 Q3 | 217.66 Thousand USD | 3926.03% |
| 2005 Q1 | -1291.00 USD | -100.28% |
| 2004 Q1 | 37.77 Thousand USD | -95.45% |
| 2004 Q4 | 456.77 Thousand USD | 313.32% |
| 2004 Q3 | 110.51 Thousand USD | 420.69% |
| 2004 Q2 | 21.22 Thousand USD | -43.81% |
| 2004 FY | 626.23 Thousand USD | -50.51% |
| 2003 Q2 | 67.7 Thousand USD | -48.8% |
| 2003 Q1 | 132.23 Thousand USD | -11.95% |
| 2003 Q3 | 232.3 Thousand USD | 243.13% |
| 2003 Q4 | 830.29 Thousand USD | 257.41% |
| 2003 FY | 1.26 Million USD | 153.03% |
| 2002 Q4 | 150.18 Thousand USD | 34.53% |
| 2002 FY | 500.11 Thousand USD | 347.64% |
| 2002 Q3 | 111.63 Thousand USD | -49.88% |
| 2002 Q2 | 222.74 Thousand USD | 1332.7% |
| 2002 Q1 | 15.54 Thousand USD | 111.23% |
| 2001 FY | -201.94 Thousand USD | 14.67% |
| 2001 Q4 | -138.48 Thousand USD | -121.86% |
| 2001 Q3 | -62.41 Thousand USD | -825.03% |
| 2001 Q2 | 8609.00 USD | 189.15% |
| 2001 Q1 | -9657.00 USD | 88.39% |
| 2000 FY | -236.66 Thousand USD | 66.62% |
| 2000 Q1 | -38.77 Thousand USD | 85.98% |
| 2000 Q4 | -83.15 Thousand USD | 50.27% |
| 2000 Q3 | -167.22 Thousand USD | -418.56% |
| 2000 Q2 | 52.49 Thousand USD | 235.37% |
| 1999 Q2 | -200 Thousand USD | -100.0% |
| 1999 Q1 | -100 Thousand USD | 87.0% |
| 1999 FY | -709.04 Thousand USD | 67.54% |
| 1999 Q3 | -200 Thousand USD | 0.0% |
| 1999 Q4 | -276.66 Thousand USD | -38.33% |
| 1998 Q2 | -600 Thousand USD | -50.0% |
| 1998 FY | -2.18 Million USD | -86.82% |
| 1998 Q3 | -300 Thousand USD | 50.0% |
| 1998 Q4 | -769.23 Thousand USD | -156.41% |
| 1998 Q1 | -400 Thousand USD | 37.15% |
| 1997 FY | -1.16 Million USD | -684.64% |
| 1997 Q3 | -400 Thousand USD | -300.0% |
| 1997 Q2 | -100 Thousand USD | -116.67% |
| 1997 Q4 | -636.47 Thousand USD | -59.12% |
| 1997 Q1 | 600 Thousand USD | 0.0% |
| 1996 FY | 200 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CareCloud, Inc. | -47.11 Million USD | 113.013% |
| Augmedix, Inc. | -18.77 Million USD | 132.648% |
| BrightSpring Health Services, Inc. Common Stock | 147.18 Million USD | 95.834% |
| CareCloud, Inc. | -47.11 Million USD | 113.013% |
| HealthEquity, Inc. | 128.13 Million USD | 95.215% |
| iCoreConnect Inc. | -10.27 Million USD | 159.66% |
| Inovalon Holdings, Inc. | 71.71 Million USD | 91.45% |
| Nutex Health, Inc. | -31.77 Million USD | 119.296% |
| Omnicell, Inc. | -34.86 Million USD | 117.583% |
| OneMedNet Corporation | -8.37 Million USD | 173.213% |
| Progyny, Inc. | 62.18 Million USD | 90.141% |
| Renalytix Plc | -29.6 Million USD | 120.707% |
| Schrödinger, Inc. | -177.44 Million USD | 103.455% |
| SOPHiA GENETICS SA | -74.82 Million USD | 108.194% |
| Streamline Health Solutions, Inc. | -19.64 Million USD | 131.206% |
| Ontrak, Inc. | -20.67 Million USD | 129.654% |
| GE HealthCare Technologies Inc. | 2.43 Billion USD | 99.748% |
| Sharecare, Inc. | -96.47 Million USD | 106.355% |
| Aclarion, Inc. | -4.87 Million USD | 225.739% |
| CareMax, Inc. | -656.15 Million USD | 100.934% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.36 Million USD | 214.224% |
| Forian Inc. | -5.59 Million USD | 209.58% |
| Bullfrog AI Holdings, Inc. Warrants | -5.36 Million USD | 214.224% |
| HeartBeam, Inc. | -15.31 Million USD | 140.035% |
| GeneDx Holdings Corp. | -163.66 Million USD | 103.746% |
| SCWorx Corp. | -1.45 Million USD | 522.635% |
| Minerva Surgical, Inc. | -30.89 Million USD | 119.842% |
| Definitive Healthcare Corp. | -329.8 Million USD | 101.859% |
| 10x Genomics, Inc. | -265.32 Million USD | 102.311% |
| Zhongchao Inc. | -13.28 Million USD | 146.154% |
| Accolade, Inc. | -114.45 Million USD | 105.357% |
| MSP Recovery, Inc. | -559.87 Million USD | 101.095% |
| R1 RCM Inc. | 147.9 Million USD | 95.855% |
| Spok Holdings, Inc. | 21.22 Million USD | 71.118% |
| Privia Health Group, Inc. | 20.64 Million USD | 70.308% |
| EUDA Health Holdings Limited | -3.96 Million USD | 254.782% |
| TruBridge, Inc. | -42.6 Million USD | 114.391% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 147.18 Million USD | 95.834% |
| Sharecare, Inc. | -96.47 Million USD | 106.355% |
| Health Catalyst, Inc. | -126.89 Million USD | 104.831% |
| GoodRx Holdings, Inc. | -27 Million USD | 122.702% |
| Premier, Inc. | 157.08 Million USD | 96.097% |
| HealthStream, Inc. | 16.01 Million USD | 61.727% |
| Certara, Inc. | -40.77 Million USD | 115.037% |
| GeneDx Holdings Corp. | -163.66 Million USD | 103.746% |
| Ontrak, Inc. | -20.67 Million USD | 129.654% |
| SHL Telemedicine Ltd. | -9 Million USD | 168.077% |
| CareCloud, Inc. | -47.11 Million USD | 113.013% |
| EUDA Health Holdings Limited | -3.96 Million USD | 254.782% |
| HeartBeam, Inc. | -15.31 Million USD | 140.035% |
| Mangoceuticals, Inc. | -9.21 Million USD | 166.505% |
| CareMax, Inc. | -656.15 Million USD | 100.934% |
| Healthcare Triangle, Inc. | -11.34 Million USD | 154.027% |
| National Research Corporation | 40.04 Million USD | 84.69% |
| Aclarion, Inc. | -4.87 Million USD | 225.739% |
| OptimizeRx Corporation | -26.4 Million USD | 123.222% |